Literature DB >> 29139012

Psychometric performance of the Romanian version of the SarQoL®, a health-related quality of life questionnaire for sarcopenia.

Andrea Ildiko Gasparik1, Gabriela Mihai2, Charlotte Beaudart3,4, Olivier Bruyere3,4, Raluca-Monica Pop5, Jean-Yves Reginster3,4, Ionela Maria Pascanu5.   

Abstract

Our study assessed the psychometric properties of the Romanian SarQoL® questionnaire. Normal distribution and high internal consistency were found. Sarcopenic subjects reported a reduced global quality of life compared to non-sarcopenics. The Romanian version of the SarQoL® questionnaire, conceptually and literally equivalent with the source instrument, is qualified in terms of psychometric properties. PURPOSE/
INTRODUCTION: We have recently provided a translated and culturally tailored version of the first quality of life (QoL) questionnaire specific for sarcopenia, the SarQoL®, in Romanian language. The aim of this study was to assess the psychometric performances of the translated questionnaire.
METHODS: A total of 100 volunteers were enrolled in the study. Sarcopenia was diagnosed according to the algorithm proposed by the European Working Group on Sarcopenia in Older People (EWGSOP). To test the psychometric performance, discriminative power, internal consistency, floor and ceiling effects, and construct validity analyses were made. We assessed the correlation between SarQoL® and similar/different domains of other two QoL questionnaires.
RESULTS: Sarcopenic subjects reported a reduced global QoL compared to non-sarcopenic individuals. Significantly (p = 0.018) higher total scores for non-sarcopenic subjects compared to those of sarcopenics indicate a good discriminative power of the Romanian questionnaire. Sarcopenic individuals had significantly lower scores in almost all domains. The Cronbach's alpha value of 0.946 indicates a high internal consistency. No floor or ceiling effects were found. A strong positive correlation was also found between similar domain scores from SF-36 and EQ-5D questionnaires with the Total SarQoL® score. Moreover, lower scores of quality of life have been shown to be significantly associated with lower muscle strength, in univariate analyses, and lower gait speed, both in univariate and multivariate analyses.
CONCLUSIONS: Our results indicate that the Romanian version of the SarQoL® questionnaire, qualified in terms of psychometric properties, could be a useful tool to assess the sarcopenia-related QoL among frail Romanian individuals.

Entities:  

Keywords:  Psychometric performance; Quality of life; Sarcopenia; Translation; Validation

Mesh:

Year:  2017        PMID: 29139012     DOI: 10.1007/s11657-017-0397-1

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  12 in total

1.  Psychometric Properties of the Chinese Version of the Sarcopenia and Quality of Life, a Quality of Life Questionnaire Specific for Sarcopenia.

Authors:  Xiaofeng Le; Yao Wei; Dingjun Hao; Lequn Shan; Xiaoli Li; Qifang Shi; Ding Ding; Xiang Cheng; Hwee Ling Eileen Lim; Bao Yi Ng
Journal:  Calcif Tissue Int       Date:  2021-05-15       Impact factor: 4.333

2.  Sarcopenia quality-of-life questionnaire (SarQoL)®: translation, cross-cultural adaptation and validation in Turkish.

Authors:  Tugba Erdogan; Serdar Eris; Suna Avci; Meryem Merve Oren; Pinar Kucukdagli; Cihan Kilic; Charlotte Beaudart; Olivier Bruyere; Mehmet Akif Karan; Gulistan Bahat
Journal:  Aging Clin Exp Res       Date:  2021-02-04       Impact factor: 3.636

3.  Cross-sectional Evaluation of the Sarcopenia Quality of Life (SarQoL) Questionnaire: Translation and Validation of its Psychometric Properties.

Authors:  Marta Dzhus; Maria Dzhus; Marta Masnyi; Myroslava Kulyk; Halyna Mostbauer; Oleksiy Ivashkivsky; Yaryna Boyko; Kateryna Cherchenko; Anton Geerinck; Jean-Yves Reginster; Olivier Bruyere; Charlotte Beaudart
Journal:  Ann Geriatr Med Res       Date:  2020-06-15

4.  THE ROMANIAN VERSION OF THE THYROID-RELATED PATIENT-REPORTED OUTCOMES THYPRO AND THYPRO-39. TRANSLATION AND ASSESSMENT OF RELIABILITY AND CROSS-CULTURAL VALIDITY.

Authors:  A E Zahan; T Watt; I Pascanu; A K Rasmussen; L Hegedüs; S J Bonnema; U Feldt-Rasmussen; J B Bjorner; V Nadasan; A Boila; I Merlan; A Borda
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Apr-Jun       Impact factor: 0.877

5.  Standard error of measurement and smallest detectable change of the Sarcopenia Quality of Life (SarQoL) questionnaire: An analysis of subjects from 9 validation studies.

Authors:  Anton Geerinck; Vidmantas Alekna; Charlotte Beaudart; Ivan Bautmans; Cyrus Cooper; Fabiana De Souza Orlandi; Jerzy Konstantynowicz; Beatriz Montero-Errasquín; Eva Topinková; Maria Tsekoura; Jean-Yves Reginster; Olivier Bruyère
Journal:  PLoS One       Date:  2019-04-29       Impact factor: 3.240

6.  Translation and validation of the Dutch SarQoL®, a quality of life questionnaire specific to sarcopenia.

Authors:  Anton Geerinck; Annelies Scheppers; Charlotte Beaudart; Olivier Bruyère; Wim Vandenbussche; René Bautmans; Sam Delye; Ivan Bautmans
Journal:  J Musculoskelet Neuronal Interact       Date:  2018-12-01       Impact factor: 2.041

7.  Spanish translation, cultural adaptation and validation of the SarQoL®: a specific health-related quality of life questionnaire for sarcopenia.

Authors:  Beatriz Montero-Errasquín; Nieves Vaquero-Pinto; Vicente Sánchez-Cadenas; Anton Geerinck; Elisabet Sánchez-García; Jesús Mateos-Nozal; José Manuel Ribera-Casado; Alfonso J Cruz-Jentoft
Journal:  BMC Musculoskelet Disord       Date:  2022-03-01       Impact factor: 2.362

8.  Quality of life in sarcopenia measured with the SarQoL®: impact of the use of different diagnosis definitions.

Authors:  Charlotte Beaudart; Médéa Locquet; Jean-Yves Reginster; Laura Delandsheere; Jean Petermans; Olivier Bruyère
Journal:  Aging Clin Exp Res       Date:  2017-12-01       Impact factor: 3.636

9.  Evaluation of the Responsiveness of the SarQoL® Questionnaire, a Patient-Reported Outcome Measure Specific to Sarcopenia.

Authors:  Anton Geerinck; Olivier Bruyère; Médéa Locquet; Jean-Yves Reginster; Charlotte Beaudart
Journal:  Adv Ther       Date:  2018-10-29       Impact factor: 3.845

10.  Correlations between the Quality of Life Domains and Clinical Variables in Sarcopenic Osteoporotic Postmenopausal Women.

Authors:  Mariana Cevei; Roxana Ramona Onofrei; Felicia Cioara; Dorina Stoicanescu
Journal:  J Clin Med       Date:  2020-02-06       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.